Complex Attention-Deficit Hyperactivity Disorder in a 4-Year-Old With Repaired Critical Congenital Heart Disease and...

Area of Science:

• Pediatric Cardiology
• Neurodevelopmental Pediatrics
• Child Psychiatry

Background:

• Congenital heart disease (CHD) is a known risk factor for developmental delays and attention-deficit hyperactivity disorder (ADHD).
• Specialized clinics monitor children with CHD for emerging developmental, learning, and behavioral issues.

Purpose of the Study:

• To present a case study on managing co-occurring ADHD in a child with complex CHD.
• To highlight the safety and efficacy of ADHD pharmacotherapy in pediatric patients with CHD.

Main Methods:

• A case presentation of a 4-year-old boy with repaired tetralogy of Fallot and a ventricular septal defect.
• Diagnosis of autism spectrum disorder and ADHD-combined type.
• Management involved medication, behavioral therapy, and close collaboration with cardiology.

Main Results:

• The child received early interventions, including special education and applied behavior analysis.
• ADHD medication was initiated and adjusted in collaboration with the cardiologist.
• The patient showed academic and social improvements with combined therapeutic and pharmacologic management.

Conclusions:

• Pharmacotherapy for ADHD is considered safe in pediatric patients with CHD.
• Careful oversight and interdisciplinary collaboration between cardiologists and prescribing clinicians are crucial.
• Behavioral therapies offer transdiagnostic benefits for co-occurring conditions like autism and ADHD.